The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It's so frustrating at the moment and I have to admit that I have all but given up on UK home use LFT sales because of our useless government.
The EU and US is where it really matters as far as LFT sales are concerned and I really do trust Alastair Smith to deliver on this.
Good luck everyone, hopefully not long to wait for that transformational RNS.
Im not sure what the benefits to Avacta would be if they took them to court.
Reputation wise you might get some points but only if they win.
Secondly, could sour further relationships for therapeutics
I’d love for someone to sue them, just not Avacta.
GLP should.
Well done on the FOI request. What has been revealed is criminal, in my opinion. Its fraud in that they accepted payment for a service and essentially failed to provide it, seemingly they had no intention of providing it. This should be dynamite in the right hands because the consequences of Government action has, again in my opinion, inflicted reputational damage. As was said at the time "if your own Government won't buy your LFT why should you expect other nations to". Its either corruption or stupidity on a monumental scale, if Avacta is aware of this I hope they instruct their legal team to take action, ODX as well. Unbelievable.
It sounds like a deliberate policy. “We will just have a couple of folks now as we get all we need from Chyna……”
Wonder if they’re contractors..
You know, longer the job is, longer they have a contract.
Probably don’t realise the impact on the UK, investors, jobs, technology development.
Just sat in an isolated bubble on £500 per day milking it.
It borders on treason the way the uk diagnostic industry have been treated over these test approval requirements when none of the Chinese ****e has had to go through the same process.
Most corrupt government and associates we’ve ever had and I was a die hard Tory.
Fantastic work there, not a single one… amazing.
Government and industry do not mix and this is the result.
20 days, plus with Boris working day and night, literally working at night whilst having a little tipple.
Don’t know how Al Smith and Colin King get so much flack…
Muller - great work, fair play.
Depressing though!
Lest we forget that spanner Bell End suggesting the blame lies with the U.K. industry. They’ve got 5 people sipping tea from the tea pot device that mad hamburger eating twunt invented. They’re literally doing nothing. The entire process was supposed to be designed to get rid of the garbage, but it turns out that’s the source of the brown envelopes so they’re left as they are and the 5 employees spend their days counting used notes instead.
RP. Totally agree, those questions need to be answered. However, as we, & odx, have issued no negative RNs, it would suggest the tests have not yet been looked at. If that's the case, an utter disgrace.
Superb. ‘We have completely c0ck blocked the entire U.K. diagnostics industry’
You have to start all over again.
I send the full attachment to Neale Hanvey, perhaps he can ask the question.
Maybe Angela Raynor too? Even Kier Starmer seemed to be showing some interest the other day.
Thanks for sharing.
As ever, a non-reply from government. So many questions raised by this response. Why have none of the 21 LFTs been approved? Have they been actively rejected or have the scientific advisers just not got round to looking at them yet? When do they expect to approve (or reject)?
Is there any facility for you to follow up on the response or do you have to start all over again?
I will do yes.
Can you get this to Neale Hanvey MP. He might find this useful.
Remember the FOI request I submitted in Nov. After chasing three times in December and providing the link to the review on the government website because they said they didn’t know what review of LFT s I was enquiring about and then they needed another 20 days to answer the request.
Here is the main response
“ Response
Please see below for responses to your queries:
How many staff are reviewing Lateral flow tests for use under the new regulations in the U.K?
There are five full time equivalent scientific advisors reviewing applications for approval under the Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations 2021 (CTDA).
How many tests have passed the review and how many companies are currently waiting for their review having meet the deadline of September 1st and paid their fee?
21 companies applied to CTDA with lateral flow devices prior to 1 September 2021. As at 17 January 2022, none of these 21 lateral flow devices have been approved under CTDA. Lateral flow devices from 13 companies are currently included on a temporary protocol (Medical Devices Regulations 2002: protocol -
1
GOV.UK (www.gov.uk)), which means that they can be sold on the private sector in the UK.”